$ETSY

WILSON FREDERICK R sold $1.5M of ETSY

WILSON FREDERICK R sold 20,000 shares of ETSY INC (ETSY) at an average of $74.39 ($73.29–$76.05, $1.49M total) across 4 trades on 2026-07-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WILSON FREDERICK R
Published Jul 6, 2026, 9:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ETSY
Neutral
medium confidence
Mentioned
$ETSY
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ETSYNeutralLow
01

Why it matters

Traders may monitor for follow-on insider activity, but this specific disclosure does not include any new Etsy business, financial, or regulatory development.

02

Market read

A director’s routine 10b5-1 sale is disclosed; it may cause minor sentiment noise but provides no new fundamental catalyst.

03

What to watch

The transaction is spread across four trades and tied to a pre-arranged plan, which reduces the likelihood of it reflecting new private information.

Relevance 5/10Novelty 4/10Timing: Filed on 2026-07-06 for a sale executed 2026-07-01.

Background

The article is an SEC Form 4 insider transaction disclosure for Etsy, showing a director’s open-market sale under a 10b5-1 plan.

Company-level read

Ticker impact

$ETSYNeutralMedium confidence
Context

ETSY discloses a director open-market sale of 20,000 shares under a pre-arranged 10b5-1 plan at $73.29–$76.05.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional fundamental catalyst from the filing alone.

Evidence & confidence

The filing is an insider sale (not a buy), but it is explicitly under a pre-arranged 10b5-1 plan and lacks any accompanying company-specific operational or guidance change.

Market effects

Minimal; this is company-specific insider activity with no sector-wide datapoint.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or sizable director sales can be read by some traders as a mild caution signal about near-term risk or liquidity needs.

Key entities

  • ETSY

    Issuer of the Form 4 insider transaction; director sold 20,000 shares under a 10b5-1 plan.

  • WILSON FREDERICK R

    Director who executed the open-market sale of 20,000 shares on 2026-07-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WMTMed

Retailers Report AI-Driven Sales, Bigger Baskets in Q2 Earnings

Walmart, Amazon, and Target reported Q2 earnings showing AI-driven sales growth. Walmart's eCommerce grew 23%, with AI assistant users spending 40% more. Amazon's Alexa for Shopping saw active users nearly double. Target's digital traffic from AI platforms grew over 3.5x faster than the industry average. Albertsons saw a 10-26% increase in order value with AI tools. Shopify's AI-referred traffic and orders tripled, but AI's impact on discovery-driven retail remains uncertain.

$ETSYHigh

Bank of America Resets Etsy Stock Price Target After Event

Bank of America upgraded Etsy to Buy, raising its price target to $105 from $88, citing structural growth. The bank expects mid-single-digit gross merchandise sales growth, higher profitability, and increased shareholder returns. Etsy's new management team is seen as key to reinvigorating growth. BofA raised its fiscal 2027 estimates for gross merchandise sales, EBITDA, and EPS.

$DEMed

Premarket movers: Deere jumps following upbeat Q3, Wolfspeed plunges

Deere shares rose 5.1% after reporting stronger-than-expected Q3 results, with EPS of $5.10 and net sales of $11B. CrowdStrike fell 2.8% following its CTO's departure. Advance Auto Parts dropped 15.9% due to lower normalized earnings. Etsy gained 3.9% after a BofA upgrade. Ultragenyx surged 11.1% on FDA approval for a gene therapy. Moderna fell 13% after a prior surge. Wolfspeed plunged 10.5% on wider-than-expected Q4 loss. Webull rose 13.8% on strong Q2 results.